Skip to content

13F-HR filed by Patient Square Capital LP

Patient Square Capital LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 11 holding rows worth $269,410,777.

Accession
0000950123-24-011804
Filed
2024-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 11 entries on the cover page, a total value of $269,410,777 stated on the cover page (in dollars after the unit check, H1), rows summing to $269,410,777 with VALUE read as dollars as filed, 13F file number 028-22927. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ROIVANT SCIENCES LTDG76279101SHS12,228,465$141,116,486dollars as filed
LIQUIDIA CORPORATION COM NEW53635D202Stock7,182,532$71,825,320dollars as filed
CULLINAN THERAPEUTICS INC230031106COM824,705$13,805,562dollars as filed
INSMED INC COM PAR $.01457669307Stock171,704$12,534,392dollars as filed
EYEPOINT INC COM NEW30233G209Stock1,361,979$10,882,212dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK325,789$7,320,479dollars as filed
PHARVARIS NVN69605108COMMON STOCK242,341$4,488,155dollars as filed
INTELLIA THERAPEUTICS INC45826J105COM128,569$2,642,093dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock90,572$2,313,209dollars as filed
OCULAR THERAPEUTIX INC67576A100COM235,498$2,048,833dollars as filed
ASTRIA THERAPEUTICS INC COM04635X102Stock39,422$434,036dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-24-011804this filing2024-11-14acceptance time not in the bulk data set